Skip to main content
main-content

Latest news

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Breaking headlines, in-depth features, hot topic review articles, and 

the latest from major international conferences brought to you by


Editor's pick

17-09-2018 | Rheumatoid arthritis | Highlight | News

No increased risk for CVD events with tocilizumab over other RA biologic DMARDs

Tocilizumab has a cardiovascular disease risk comparable with that of etanercept and other biologic DMARDs in individuals with rheumatoid arthritis, according to findings from a large, retrospective cohort study using real-world data.

Source:

Arthritis Care Res 2018; doi:10.1002/acr.23737

Latest headlines

19-09-2018 | Osteoarthritis | News

Extended-release triamcinolone acetonide viable for osteoarthritis patients with type 2 diabetes

Triamcinolone acetonide extended-release may be a good option for the treatment of knee osteoarthritis in patients with comorbid type 2 diabetes, suggest phase II study findings.

17-09-2018 | Rheumatoid arthritis | Highlight | News

No increased risk for CVD events with tocilizumab over other RA biologic DMARDs

Tocilizumab has a cardiovascular disease risk comparable with that of etanercept and other biologic DMARDs in individuals with rheumatoid arthritis, according to findings from a large, retrospective cohort study using real-world data.

14-09-2018 | Rheumatoid arthritis | News

Early RA disease activity lower with methotrexate combination than methotrexate alone

Methotrexate–hydroxychloroquine combination therapy is associated with lower disease activity than methotrexate alone in early rheumatoid arthritis, according to a head-to-head comparison published in Rheumatology.

In depth

07-09-2018 | Treatment | Feature | Article

At a glance: Common scores used in rheumatology

A quick-reference guide to the scores that are commonly used in clinical trials and daily rheumatology practice.

Transitioning from pediatric to adult rheumatology care

In this medwireNews podcast, we talk to Editorial Board member Sangeeta Sule about how patients with juvenile arthritis transition from pediatric to adult care, the challenges associated with this transition, and how the process can be improved.

20-08-2018 | Psoriatic arthritis | Feature | Article

Into the clinic: Ixekizumab for the treatment of PsA

medwireNews summarizes the key data supporting the approval of ixekizumab for the treatment of psoriatic arthritis, and discusses its place in the treatment landscape with Philip Mease and Laura Coates.

image credits